Clinical Trial Update: Double-blind Comparative Randomized Multicenter [Phase 3]

View source ↗

Summary

Phase 3 double-blind randomized multicenter trial for cerebral palsy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cerebral Palsy

Snippet

Sponsor: Innopharm LLC | Conditions: Cerebral Palsy (CP) | Phase 3 | Status: COMPLETED